Medicare Enrolled
Dr. Shravanti Macherla, M.D
Internal Medicine · Gainesville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Macherla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Macherla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Macherla
Dr. Shravanti Macherla is an internal medicine specialist in Gainesville, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Macherla performed 51,093 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Macherla received a total of $13,186 from 76 pharmaceutical and/or device companies across 638 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Macherla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 0% volume in GA
$13,186 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗51,093
Medicare services
Top 0% in GA for internal medicine
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
22,500 | $1 | $5 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
16,320 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 4,200 | $18 | $37 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,804 | $0 | $2 |
| Injection, granisetron hydrochloride, 100 mcg | 1,410 | $0 | $10 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
737 | $8 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
660 | $92 | $160 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
631 | $8 | $45 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
566 | $10 | $65 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
220 | $21 | $95 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
215 | $10 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
214 | $93 | $650 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
214 | $6 | $300 |
| Annual depression screening | 204 | $16 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $61 | $115 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
151 | $1 | $10 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
120 | $47 | $170 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
74 | $21 | $175 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
73 | $11 | $55 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
72 | $73 | $115 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
71 | $47 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $123 | $245 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
60 | $6 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
54 | $135 | $225 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
43 | $16 | $100 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
40 | $29 | $130 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
31 | $17 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
31 | $49 | $115 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
30 | $13 | $100 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
26 | $19 | $70 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
26 | $55 | $109 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
25 | $2 | $40 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
22 | $27 | $90 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
14 | $15 | $110 |
| New patient office visit, complex (60-74 min) | 12 | $161 | $310 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
77.3% high complexity
15.9% medium
6.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,186
Total received (2018-2024)
Avg $1,884/year across 7 years
Top 5% in GA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
638
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,203
2023
$2,506
2022
$2,263
2021
$1,379
2020
$539
2019
$1,753
2018
$1,543
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$857
PFIZER INC.
$284
Merck Sharp & Dohme LLC
$203
Janssen Biotech, Inc.
$200
Celgene Corporation
$110
Lilly USA, LLC
$102
Genentech USA, Inc.
$100
ABBVIE INC.
$99
Daiichi Sankyo Inc.
$97
E.R. Squibb & Sons, L.L.C.
$88
Astellas Pharma US Inc
$83
AstraZeneca Pharmaceuticals LP
$79
Eisai Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$72
Stemline Therapeutics Inc.
$68
Gilead Sciences, Inc.
$66
Regeneron Healthcare Solutions, Inc.
$58
Aveo Pharmaceuticals, Inc.
$58
GlaxoSmithKline, LLC.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$52
Exelixis Inc.
$45
SERVIER PHARMACEUTICALS LLC
$38
TerSera Therapeutics LLC
$30
Tempus AI, Inc
$30
SOBI, INC
$29
GENZYME CORPORATION
$23
JAZZ PHARMACEUTICALS INC.
$23
Incyte Corporation
$22
PUMA BIOTECHNOLOGY, INC.
$22
BeiGene USA, Inc.
$22
Mirati Therapeutics, Inc.
$21
Deciphera Pharmaceuticals Inc.
$21
Coherus Biosciences Inc.
$19
Rigel Pharmaceuticals, Inc.
$19
ARRAY BIOPHARMA INC
$17
MorphoSys, US Inc.
$17
Top 3 companies account for 41.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,846
PFIZER INC.
$716
E.R. Squibb & Sons, L.L.C.
$603
Incyte Corporation
$602
Janssen Biotech, Inc.
$583
Lilly USA, LLC
$568
Celgene Corporation
$551
Astellas Pharma US Inc
$516
Seagen Inc.
$491
Merck Sharp & Dohme LLC
$458
Daiichi Sankyo Inc.
$335
AstraZeneca Pharmaceuticals LP
$319
Eisai Inc.
$309
Amgen Inc.
$308
Genentech USA, Inc.
$303
Takeda Pharmaceuticals U.S.A., Inc.
$244
JAZZ PHARMACEUTICALS INC.
$215
Merck Sharp & Dohme Corporation
$214
GENZYME CORPORATION
$177
Pharmacyclics LLC, An AbbVie Company
$175
Bayer HealthCare Pharmaceuticals Inc.
$145
Regeneron Healthcare Solutions, Inc.
$137
Stemline Therapeutics Inc.
$136
GlaxoSmithKline, LLC.
$135
Karyopharm Therapeutics Inc.
$134
TerSera Therapeutics LLC
$134
Gilead Sciences, Inc.
$128
Alexion Pharmaceuticals, Inc.
$122
ABBVIE INC.
$121
Deciphera Pharmaceuticals Inc.
$116
Boehringer Ingelheim Pharmaceuticals, Inc.
$113
Exelixis Inc.
$105
Bayer Healthcare Pharmaceuticals Inc.
$101
NOVARTIS PHARMACEUTICALS CORPORATION
$100
EMD Serono, Inc.
$99
Pharmacyclics LLC, an AbbVie Company
$97
Rigel Pharmaceuticals, Inc.
$93
EISAI INC.
$92
TESARO, Inc.
$81
Myovant Sciences Inc.
$75
SERVIER PHARMACEUTICALS LLC
$72
PUMA BIOTECHNOLOGY, INC.
$71
Puma Biotechnology, Inc.
$70
Agios Pharmaceuticals, Inc.
$69
BTG International, Inc.
$68
SANOFI-AVENTIS U.S. LLC
$67
BeiGene USA, Inc.
$63
AbbVie, Inc.
$60
Acceleron Pharma, Inc.
$58
Aveo Pharmaceuticals, Inc.
$58
Coherus Biosciences Inc.
$56
Janssen Pharmaceuticals, Inc
$55
ARRAY BIOPHARMA INC
$55
AMAG Pharmaceuticals, Inc.
$51
Dendreon Pharmaceuticals LLC
$45
Epizyme, Inc.,
$37
MorphoSys, US Inc.
$36
INSYS Therapeutics Inc
$35
Jazz Pharmaceuticals Inc.
$34
Tempus AI, Inc
$30
SOBI, INC
$29
Kite Pharma, Inc.
$27
TAIHO ONCOLOGY, INC.
$27
Shire North American Group Inc
$25
Ipsen Biopharmaceuticals, Inc
$24
ADC Therapeutics America, Inc.
$24
Mirati Therapeutics, Inc.
$21
AbbVie Inc.
$17
CTI BioPharma Corp.
$17
Blueprint Medicines Corporation
$16
Collegium Pharmaceutical, Inc.
$15
Seattle Genetics, Inc.
$14
Novo Nordisk Inc
$14
Secura Bio, Inc.
$12
Spectrum Pharmaceuticals Inc.
$11
Kyowa Kirin, Inc.
$11
Top 3 companies account for 24.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADYNOVATE · AFINITOR · ALIMTA · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · DARZALEX · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · Enhertu · Erleada · FARYDAK · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAUCHER-DISEASE · GAVRETO · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · NOXAFIL · Nerlynx · Neulasta · NovoSeven RT · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETACRIT · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VORAXAZE · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTAMPZAER · XTANDI · Xermelo · Xospata · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
335
County median income
$77,430
Nearest hospital to ZIP centroid (approximate)
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Macherla is a mixed practice specialist, with above-average Medicare volume (top 0% in GA), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Macherla experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Macherla performed 22,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Macherla receive payments from pharmaceutical companies?
Yes. Dr. Macherla received a total of $13,186 from 76 companies across 638 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Macherla's costs compare to other internal medicine physicians in Gainesville?
Dr. Macherla's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Macherla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Gainesville
Browse internal medicine physicians in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in GA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in GA
Which GA internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology